Showing results (191-200 of 637) with videos related to
Sort By:
Pageof 64
International Journal of Geriatric Psychiatry|May 9, 2026
Racial and Ethnic Representation in Dementia Clinical Trials Registered on ClinicalTrials.gov in the United States, United Kingdom, and CanadaDaniel Kramarczyk, Clive Ballard, Anne Corbett, et al.The Gerontologist|July 28, 2019
Associations of Awareness of Age-Related Change With Emotional and Physical Well-being: A Systematic Review and Meta-analysisSerena Sabatini, Barbora Silarova, Anthony Martyr, et al.Journal of Cardiothoracic and Vascular Anesthesia|December 29, 2019
Intraoperative Optimization of Both Depth of Anesthesia and Cerebral Oxygenation in Elderly Patients Undergoing Coronary Artery Bypass Graft Surgery-A Randomized Controlled Pilot TrialGudrun Kunst, Nathan Gauge, Kiran Salaunkey, et al.Nature Reviews. Disease Primers|July 2, 2021
Parkinson disease-associated cognitive impairmentDag Aarsland, Lucia Batzu, Glenda M Halliday, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 4, 2024
Sports-related concussion not associated with long-term cognitive or behavioural deficits: the PROTECT-TBI studyMatthew Joseph Lennon, Grant Rigney, Byron Creese, et al.Nature Reviews. Neurology|January 5, 2022
Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunitiesZahinoor Ismail, Byron Creese, Dag Aarsland, et al.International Journal of Geriatric Psychiatry|September 10, 2011
Depression in mild dementia: associations with diagnosis, APOE genotype and clinical featuresFriederike Fritze, Uwe Ehrt, Hogne Sønnesyn, et al.Dementia and Geriatric Cognitive Disorders|November 19, 2011
Early and presenting symptoms of dementia with lewy bodiesEirik Auning, Arvid Rongve, Tormod Fladby, et al.BMJ Mental Health|July 23, 2024
Parkinson's disease psychosis associated with accelerated multidomain cognitive declineSara Pisani, Luca Gosse, Dag Aarsland, et al.Lancet (London, England)|November 5, 2013
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trialJeffrey Cummings, Stuart Isaacson, Roger Mills, et al.Pageof 64